NYSE:CORHealthcare
Vanguard’s 7.3% Cencora Stake Highlights Valuation Gap And Risks
Vanguard Capital Management has disclosed a 7.3% stake in Cencora (NYSE:COR) via a Schedule 13G filing.
The filing identifies Vanguard as one of Cencora’s largest institutional holders and classifies the position as being held for investment purposes.
Cencora operates as a major player in pharmaceutical distribution and related healthcare services, sitting at the center of drug supply chains that connect manufacturers, pharmacies, and providers. With its scale and logistics capabilities,...